1
|
Ardalan ZS, Yao CK, Green K, Probert C, Gill PA, Rosella S, Muir JG, Sparrow MP, Gibson PR. A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effects. JGH Open 2023; 7:942-952. [PMID: 38162853 PMCID: PMC10757501 DOI: 10.1002/jgh3.13008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 10/24/2023] [Accepted: 11/07/2023] [Indexed: 01/03/2024]
Abstract
Aims To evaluate a whole-food diet strategy (the Monash Pouch diet [MPD]) designed based on the interacting roles dietary factors play with pouch health. Specifically, its tolerability and acceptability, whether it achieved its dietary and metabolic goals, and the effects on symptoms and inflammation were examined. Methods In a 6-week open-label trial, patients with ileoanal pouches educated on the MPD were assessed regarding diet tolerability and acceptance, food intake (7-day food diaries), pouch-related symptoms (clinical pouchitis disease activity index), and, in 24-h fecal samples, calprotectin, fermentative biomarkers, and volatile organic compounds (VOC). Results Of 12 patients, 6 male, mean (SD) age 55 (5) and pouch age 13 (2) years, one withdrew with partial small bowel obstruction. Tolerability was excellent in 9 (75%) and acceptance was high (81%). Targeted changes in dietary intake were achieved. Fecal branched- to short-chain fatty acid ratio increased by median 60 [IQR: 11-80]% (P = 0.02). Fecal VOCs for 3 compounds were also increased, 2-methyl-5-propan-2-ylcyclohexa-1,3-diene (Fold-change [FC] 2.08), 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane (FC 3.86), propan-2-ol (FC 2.10). All six symptomatic patients achieved symptomatic remission (P = 0.03). Fecal calprotectin at baseline was 292 [176-527] μg/g and at week 5 was 205 [148-310] μg/g (P = 0.72). Conclusion Well tolerated and accepted, the MPD achieved targeted changes in intakes and fermentation of carbohydrates relative to that of protein. There were signals of improvement in symptoms. These results indicate the need for a randomized-controlled trial. (Trial registration: ACTRN12621000374864; https://www.anzctr.org.au/ACTRN12621000374864.aspx).
Collapse
Affiliation(s)
- Zaid S Ardalan
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Chu K Yao
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Kraig Green
- Department of Molecular and Clinical Cancer MedicineUniversity of LiverpoolLiverpoolUK
| | - Chris Probert
- Department of Molecular and Clinical Cancer MedicineUniversity of LiverpoolLiverpoolUK
| | - Paul A Gill
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Sam Rosella
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Jane G Muir
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Miles P Sparrow
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| | - Peter R Gibson
- Department of Gastroenterology, Central Clinical SchoolMonash University and Alfred HealthMelbourneVictoriaAustralia
| |
Collapse
|
2
|
Bowman R, Walters B, Smith V, Prise KL, Handley SE, Green K, Mankad K, O'Hare P, Dahl C, Jorgensen M, Opocher E, Hargrave D, Thompson DA. Visual outcomes and predictors in optic pathway glioma: a single centre study. Eye (Lond) 2023; 37:1178-1183. [PMID: 35562551 PMCID: PMC10101957 DOI: 10.1038/s41433-022-02096-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Revised: 03/31/2022] [Accepted: 05/06/2022] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND/AIMS Optic pathway gliomas (OPGs) may cause progressive visual loss despite chemotherapy. Newer, less toxic treatments might be given earlier, depending on visual prognosis. We aimed to investigate the prognostic value of visual evoked potentials (VEP) and optical coherence tomography (OCT). METHODS A retrospective study of OPG patients (treated 2003-2017) was conducted. Primary outcome was PEDIG category visual acuity in better and worse eyes (good < = 0.2, moderate 0.3-0.6 and poor > = 0.7 logMAR). Binary logistic regression analysis was used to identify predictors of these outcomes. RESULTS 60 patients (32 Neurofibromatosis type 1 [NF1] and 28 sporadic) had median presentation age 49 months (range 17-183) (NF1) and 27 months (range 4-92) (sporadic). Median follow up was 82 months (range 12-189 months). At follow up 24/32 (75%) of NF1 children and 14/28 (50%) of sporadic children had good better eye visual acuity and 11/32 (34%) of NF1 children and 15/28 (54%) of sporadics had poor worse eye acuity. Mean peripapillary retinal nerve fibre layer (RNFL) thickness predicted good better eye final acuity (OR 0.799, 95%CI 0.646-0.987, p = 0.038). Presenting with visual symptoms (OR 0.22 95% CI 0.001-0.508, p = 0.017) and poorer VEP scores (OR 2.35 95% CI 1.1-5.03, p = 0.027) predicted poor worse eye final acuity. 16 children had homonymous hemianopias at follow up, predicted by poor presenting binocular VEP score (OR 1.449 95%CI 1.052-1.995, p = 0.02). CONCLUSIONS We found that both RNFL thickness on OCT and VEP were useful in predicting future visual acuity and vision and potentially in planning treatment. We had a high prevalence of homonymous hemianopia.
Collapse
Affiliation(s)
- R Bowman
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England.
- University College London, Great Ormond Street Institute of Child Health, WC1N 1EH, London, England.
| | - B Walters
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - V Smith
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - K L Prise
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - S E Handley
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
- University College London, Great Ormond Street Institute of Child Health, WC1N 1EH, London, England
| | - K Green
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - K Mankad
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
- University College London, Great Ormond Street Institute of Child Health, WC1N 1EH, London, England
| | - P O'Hare
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - C Dahl
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - M Jorgensen
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - E Opocher
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
| | - D Hargrave
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
- University College London, Great Ormond Street Institute of Child Health, WC1N 1EH, London, England
| | - D A Thompson
- Great Ormond Street Hospital, Great Ormond Street NHS Foundation Trust, WC1N 3JH, London, England
- University College London, Great Ormond Street Institute of Child Health, WC1N 1EH, London, England
| |
Collapse
|
3
|
Lewandowska A, Thornell I, Soutar C, Green K, Lange J, Miller D, Tarara T, Pogorelov T, Rienstra C, Welsh M, Weers J, Burke M. 607 A rationally designed molecular prosthetic for cystic fibrosis. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01297-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
4
|
Godsel L, Koetsier J, Harmon R, Hegazy M, Huffine A, McCullough C, Svoboda S, Luass L, Prakriya M, Perez White B, Green K. 406 Modulation of calcium channel activity in Darier’s disease keratinocytes improves disease phenotypes. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Burks H, Roth-Carter Q, Godsel L, Xing X, Tsoi L, Kirma J, Gudjonsson J, Green K. 468 Transcriptional profiling of the rare acantholytic disorders Darier disease, Hailey-Hailey disease, and Grover's disease suggests common mechanisms of pathogenesis. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
6
|
Perl A, Koetsier J, Roselli S, Panicker N, Verrills N, Green K. 401 PP2A-B55α dephosphorylates desmoplakin's C-terminus to regulate cell adhesion. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
7
|
Jones WS, Suklan J, Winter A, Green K, Craven T, Bruce A, Mair J, Dhaliwal K, Walsh T, Simpson AJ, Graziadio S, Allen AJ. Diagnosing ventilator-associated pneumonia (VAP) in UK NHS ICUs: the perceived value and role of a novel optical technology. Diagn Progn Res 2022; 6:5. [PMID: 35144691 PMCID: PMC8830125 DOI: 10.1186/s41512-022-00117-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Accepted: 01/12/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Diagnosing ventilator-associated pneumonia (VAP) in an intensive care unit (ICU) is a complex process. Our aim was to collect, evaluate and represent the information relating to current clinical practice for the diagnosis of VAP in UK NHS ICUs, and to explore the potential value and role of a novel diagnostic for VAP, which uses optical molecular alveoscopy to visualise the alveolar space. METHODS Qualitative study performing semi-structured interviews with clinical experts. Interviews were recorded, transcribed, and thematically analysed. A flow diagram of the VAP patient pathway was elicited and validated with the expert interviewees. Fourteen clinicians were interviewed from a range of UK NHS hospitals: 12 ICU consultants, 1 professor of respiratory medicine and 1 professor of critical care. RESULTS Five themes were identified, relating to [1] current practice for the diagnosis of VAP, [2] current clinical need in VAP diagnostics, [3] the potential value and role of the technology, [4] the barriers to adoption and [5] the evidence requirements for the technology, to help facilitate a successful adoption. These themes indicated that diagnosis of VAP is extremely difficult, as is the decision to stop antibiotic treatment. The analysis revealed that there is a clinical need for a diagnostic that provides an accurate and timely diagnosis of the causative pathogen, without the long delays associated with return of culture results, and which is not dangerous to the patient. It was determined that the technology would satisfy important aspects of this clinical need for diagnosing VAP (and pneumonia, more generally), but would require further evidence on safety and efficacy in the patient population to facilitate adoption. CONCLUSIONS Care pathway analysis performed in this study was deemed accurate and representative of current practice for diagnosing VAP in a UK ICU as determined by relevant clinical experts, and explored the value and role of a novel diagnostic, which uses optical technology, and could streamline the diagnostic pathway for VAP and other pneumonias.
Collapse
Affiliation(s)
- W S Jones
- NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK.
- NIHR Newcastle In Vitro Diagnostics Co-operative, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
| | - J Suklan
- NIHR Newcastle In Vitro Diagnostics Co-operative, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
| | - A Winter
- NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK
| | - K Green
- NIHR Newcastle In Vitro Diagnostics Co-operative, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
| | - T Craven
- Translational Healthcare Technologies Group, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
- Edinburgh Critical Care Research Group, University of Edinburgh, Edinburgh, UK
| | - A Bruce
- Translational Healthcare Technologies Group, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
| | - J Mair
- Translational Healthcare Technologies Group, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
| | - K Dhaliwal
- Translational Healthcare Technologies Group, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
| | - T Walsh
- Edinburgh Critical Care Research Group, University of Edinburgh, Edinburgh, UK
| | - A J Simpson
- NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK
- NIHR Newcastle In Vitro Diagnostics Co-operative, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
| | - S Graziadio
- NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK
| | - A J Allen
- NIHR Newcastle In Vitro Diagnostics Co-operative, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
| |
Collapse
|
8
|
Chernos M, MacDonald RJ, Straker J, Green K, Craig JR. Simulating the cumulative effects of potential open-pit mining and climate change on streamflow and water quality in a mountainous watershed. Sci Total Environ 2022; 806:150394. [PMID: 34571236 DOI: 10.1016/j.scitotenv.2021.150394] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Revised: 09/09/2021] [Accepted: 09/13/2021] [Indexed: 06/13/2023]
Abstract
Land use and climate change effects on water quality and water quantity are well documented globally. Most studies evaluate individual factors and effects, without considering the interrelationships between land use, climate, water quality, and water quantity. This study provides an integrated assessment of the cumulative effects of climate change and potential open-pit coal mining on streamflow and water quality in the Oldman River Basin, Alberta, Canada. A hydrological model was developed that incorporates estimates of future selenium loading, water use, and projected changes in air temperature and precipitation to evaluate changes in water quantity and quality. Model results indicate that estimated selenium concentrations, absent any attenuation, are likely to be substantially above most water quality guidelines and strong reliance on mitigation technologies would be required to maintain adequate water quality in the watershed if mine development were to take place. Streamflow is sensitive to changes in climatic conditions, and modelling results suggest there are likely to be increases in winter flow, earlier peak flow, and reductions in flow during the summer and fall months under the climate change scenarios. These changes can have direct impacts on the degree of selenium dilution and more generally on aquatic habitat, ecosystem health, and socioeconomic needs. This study highlights that water management decisions may mis-evaluate the risks and tradeoffs of future mine development if they fail to adequately consider climate change and changing streamflow regimes and their indirect effects on water quality.
Collapse
Affiliation(s)
- M Chernos
- MacDonald Hydrology Consultants Ltd., Cranbrook, British Columbia, Canada.
| | - R J MacDonald
- MacDonald Hydrology Consultants Ltd., Cranbrook, British Columbia, Canada
| | - J Straker
- Integral Ecology Group, Duncan, British Columbia, Canada
| | - K Green
- Apex Geoscience Consultants Ltd., Nelson, British Columbia, Canada
| | - J R Craig
- Department of Civil and Environmental Engineering, University of Waterloo, Waterloo, Canada
| |
Collapse
|
9
|
Burks H, Arnette C, Koetsier J, Broussard J, Roth-Carter Q, Gerami P, Johnson J, Green K. 532 Keratinocyte desmoglein 1 as a target and mediator of paracrine signaling in the melanoma niche. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Hegazy M, Nekrasova O, Koetsier J, Broussard J, Huffine A, Godsel L, Green K. 099 Retromer-dependent Dsg1 trafficking promotes epidermal differentiation and is enhanced by a small molecule chaperone. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Escudero-Abarca BI, Goulter RM, Arbogast JW, Leslie RA, Green K, Jaykus LA. Efficacy of alcohol-based hand sanitizers against human norovirus using RNase-RT-qPCR with validation by human intestinal enteroid replication. Lett Appl Microbiol 2020; 71:605-610. [PMID: 32964478 PMCID: PMC7756425 DOI: 10.1111/lam.13393] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Revised: 09/14/2020] [Accepted: 09/14/2020] [Indexed: 12/14/2022]
Abstract
Successful human norovirus (HuNoV) cultivation in stem cell‐derived human intestinal enteroids (HIE) was recently reported. The purpose of this study was to evaluate the anti‐HuNoV efficacy of two alcohol‐based commercial hand sanitizers and 60% ethanol by suspension assay using RNase‐RT‐qPCR, with subsequent validation of efficacy by HuNoV cultivation using the HIE model. In suspension, when evaluated by RNase‐RT‐qPCR, 60% ethanol resulted in less than one log10 reduction in HuNoV genome equivalent copies (GEC) regardless of contact time (30 or 60s) or soil load. The two commercial products outperformed 60% ethanol regardless of contact time or soil load, providing 2·2–3·2 log10 HuNoV GEC reductions by suspension assay. Product B could not be validated in the HIE model due to cytotoxicity. Following a 60s exposure, viral replication in the HIE model increased 1·9 ± 0·2 log10 HuNoV GEC for the neutralization (positive) control and increased 0·9 ± 0·2 log10 HuNoV GEC in challenged HIE after treatment with 60% ethanol. No HuNoV replication in HIE was observed after a 60 s exposure to Product A.
Collapse
Affiliation(s)
- B I Escudero-Abarca
- Department of Food Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA
| | - R M Goulter
- Department of Food Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA
| | | | | | - K Green
- GOJO Industries Inc, Akron, OH, USA
| | - L-A Jaykus
- Department of Food Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA
| |
Collapse
|
12
|
Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada. Clin Infect Dis 2020; 69:970-979. [PMID: 30508064 DOI: 10.1093/cid/ciy1009] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Accepted: 11/30/2018] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Recent studies have demonstrated the possibility of negative associations between prior influenza vaccines and subsequent influenza vaccine effectiveness (VE), depending on season and strain. We investigated this association over 4 consecutive influenza seasons (2011-2012 through 2014-2015) in Canada. METHODS Using a matched test-negative design, laboratory-confirmed influenza cases and matched test-negative controls admitted to hospitals were enrolled. Patients were stratified into 4 groups according to influenza vaccine history (not vaccinated current and prior season [referent], vaccinated prior season only, vaccinated current season only, and vaccinated both current and prior season). Conditional logistic regression was used to estimate VE; prior vaccine impact was assessed each season for overall effect and effect stratified by age (<65 years, ≥65 years) and type/subtype (A/H1N1, A/H3N2, influenza B). RESULTS Overall, mainly nonsignificant associations were observed. Trends of nonsignificant decreased VE among patients repeatedly vaccinated in both prior and current season relative to the current season only were observed in the A/H3N2-dominant seasons of 2012-2013 and 2014-2015. Conversely, in 2011-2012, during which B viruses circulated, and in 2013-2014, when A/H1N1 circulated, being vaccinated in both seasons tended to result in a high VE in the current season against the dominant circulating subtype. CONCLUSIONS Prior vaccine impact on subsequent VE among Canadian inpatients was mainly nonsignificant. Even in circumstances where we observed a trend of negative impact, being repeatedly vaccinated was still more effective than not receiving the current season's vaccine. These findings favor continuation of annual influenza vaccination recommendations, particularly in older adults. CLINICAL TRIALS REGISTRATION NCT01517191.
Collapse
Affiliation(s)
- M K Nichols
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - M K Andrew
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - L Ye
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - T F Hatchette
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - A Ambrose
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - G Boivin
- Centre Hospitalier Universitaire de Québec, Québec City, Canada
| | - W Bowie
- University of British Columbia, Vancouver, Canada
| | - G Dos Santos
- Business and Decision Life Sciences, Bruxelles, Belgium.,Present affiliation: GSK, Wavre, Belgium
| | - M Elsherif
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - K Green
- Mount Sinai Hospital, Toronto, Ontario, Canada
| | | | - K Katz
- North York General Hospital, Toronto
| | - J Leblanc
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | - M Loeb
- McMaster University, Hamilton
| | - D MacKinnon-Cameron
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | | | | | - A McGeer
- Mount Sinai Hospital, Toronto, Ontario, Canada
| | - J Powis
- Michael Garron Hospital, Toronto
| | | | - M Semret
- McGill University, Montreal, Québec
| | - R Sharma
- GSK, Mississauga, Ontario, Canada
| | - V Shinde
- GSK, King of Prussia, Pennsylvania.,Present affiliation: Novavax Vaccines, Washington, D.C
| | - D Smyth
- The Moncton Hospital, New Brunswick
| | - S Trottier
- Centre Hospitalier Universitaire de Québec, Québec City, Canada
| | | | - D Webster
- Saint John Hospital Regional Hospital, Dalhousie University, New Brunswick, Canada
| | - S A McNeil
- Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia
| | | |
Collapse
|
13
|
Kazaglis L, Hsia J, Green K, Iber C. 0706 Comparing the Dose-Response Curves of Upper Airway Stimulation and CPAP Usage on Changes in Epworth Sleepiness Scale. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Upper Airway Stimulation (UAS) and Continuous Positive Airway Pressure (CPAP) are trackable therapies for obstructive sleep apnea. We used recent big-data cohorts to compare changes in sleepiness versus usage.
Methods
ADHERE is an international registry of real-world UAS outcomes from 2016 to date. General UAS criteria are CPAP intolerance, AHI 15-65 (<25% central+mixed), and suggested BMI≤35. Baseline ESS is collected from the medical record, and follow-up ESS and usage is collected 2-4 months after therapy activation. M Health Fairview maintains a database of cross-linked CPAP and EHR data. All new adult sleep patients from 2015 onward were included paralleling ADHERE: BMI≤35, AHI 15-65, and daily CPAP-EHR data starting at least 60 days prior to 2nd ESS measurement. Baseline ESS was collected at consult, and follow-up ESS was collected approximately 6 months later. Device-reported usage hours were compared with the changes in ESS from baseline.
Results
UAS (n=690) and CPAP (n=514) groups were similar: age 59.7±10.8 versus 59.7±13.6, 78% versus 75% male, and AHI 35.3±14.4 versus 33.8±14.0. UAS group was slightly less obese, BMI 29.3±3.9 versus 30.0±3.4 (p=0.001), with higher baseline ESS, 11.4±5.6 versus 8.6±5.3 (p<0.001). UAS usage was higher at 6.4±2.0 hours/night versus 5.2±2.0 hours/night with CPAP (p<0.001). UAS group average ESS decreased 2.5 points for patients with 0-4 hours of use (n=81), decreasing to 3.8 points with at 4 or more hours of use (n=609). CPAP group average ESS decreased 2.5 points for patients with 0-4 hours of use (n=125), decreasing to 3.3 points with at 4 or more hours of use (n=389).
Conclusion
Compared to prior works and the UAS cohort, this CPAP cohort was more likely to have normal ESS at baseline. UAS and CPAP both demonstrate a dose-response curve associating increasing hourly usage with larger ESS reductions.
Support
Kent Lee of Inspire Medical Systems provided background information and access to a de-identified ADHERE data set for analysis.
Collapse
Affiliation(s)
| | - J Hsia
- M Health Fairview, Minneapolis, MN
| | - K Green
- University of Colorado, Denver, CO
| | - C Iber
- M Health Fairview, Minneapolis, MN
| |
Collapse
|
14
|
Abel C, Afach S, Ayres NJ, Baker CA, Ban G, Bison G, Bodek K, Bondar V, Burghoff M, Chanel E, Chowdhuri Z, Chiu PJ, Clement B, Crawford CB, Daum M, Emmenegger S, Ferraris-Bouchez L, Fertl M, Flaux P, Franke B, Fratangelo A, Geltenbort P, Green K, Griffith WC, van der Grinten M, Grujić ZD, Harris PG, Hayen L, Heil W, Henneck R, Hélaine V, Hild N, Hodge Z, Horras M, Iaydjiev P, Ivanov SN, Kasprzak M, Kermaidic Y, Kirch K, Knecht A, Knowles P, Koch HC, Koss PA, Komposch S, Kozela A, Kraft A, Krempel J, Kuźniak M, Lauss B, Lefort T, Lemière Y, Leredde A, Mohanmurthy P, Mtchedlishvili A, Musgrave M, Naviliat-Cuncic O, Pais D, Piegsa FM, Pierre E, Pignol G, Plonka-Spehr C, Prashanth PN, Quéméner G, Rawlik M, Rebreyend D, Rienäcker I, Ries D, Roccia S, Rogel G, Rozpedzik D, Schnabel A, Schmidt-Wellenburg P, Severijns N, Shiers D, Tavakoli Dinani R, Thorne JA, Virot R, Voigt J, Weis A, Wursten E, Wyszynski G, Zejma J, Zenner J, Zsigmond G. Measurement of the Permanent Electric Dipole Moment of the Neutron. Phys Rev Lett 2020; 124:081803. [PMID: 32167372 DOI: 10.1103/physrevlett.124.081803] [Citation(s) in RCA: 46] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Accepted: 02/03/2020] [Indexed: 06/10/2023]
Abstract
We present the result of an experiment to measure the electric dipole moment (EDM) of the neutron at the Paul Scherrer Institute using Ramsey's method of separated oscillating magnetic fields with ultracold neutrons. Our measurement stands in the long history of EDM experiments probing physics violating time-reversal invariance. The salient features of this experiment were the use of a ^{199}Hg comagnetometer and an array of optically pumped cesium vapor magnetometers to cancel and correct for magnetic-field changes. The statistical analysis was performed on blinded datasets by two separate groups, while the estimation of systematic effects profited from an unprecedented knowledge of the magnetic field. The measured value of the neutron EDM is d_{n}=(0.0±1.1_{stat}±0.2_{sys})×10^{-26} e.cm.
Collapse
Affiliation(s)
- C Abel
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - S Afach
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - N J Ayres
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - C A Baker
- STFC Rutherford Appleton Laboratory, Harwell, Didcot, Oxon OX11 0QX, United Kingdom
| | - G Ban
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - G Bison
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - K Bodek
- Marian Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Cracow, Poland
| | - V Bondar
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - M Burghoff
- Physikalisch Technische Bundesanstalt, D-10587 Berlin, Germany
| | - E Chanel
- Laboratory for High Energy Physics and Albert Einstein Center for Fundamental Physics, University of Bern, CH-3012 Bern, Switzerland
| | - Z Chowdhuri
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - P-J Chiu
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - B Clement
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - C B Crawford
- University of Kentucky, 40506 Lexington, Kentucky, USA
| | - M Daum
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - S Emmenegger
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - L Ferraris-Bouchez
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - M Fertl
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
- Institute of Physics, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - P Flaux
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - B Franke
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - A Fratangelo
- Laboratory for High Energy Physics and Albert Einstein Center for Fundamental Physics, University of Bern, CH-3012 Bern, Switzerland
| | - P Geltenbort
- Institut Laue-Langevin, CS 20156 F-38042 Grenoble Cedex 9, France
| | - K Green
- STFC Rutherford Appleton Laboratory, Harwell, Didcot, Oxon OX11 0QX, United Kingdom
| | - W C Griffith
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - M van der Grinten
- STFC Rutherford Appleton Laboratory, Harwell, Didcot, Oxon OX11 0QX, United Kingdom
| | - Z D Grujić
- Physics Department, University of Fribourg, CH-1700 Fribourg, Switzerland
- Institute of Physics Belgrade, University of Belgrade, 11080 Belgrade, Serbia
| | - P G Harris
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - L Hayen
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - W Heil
- Institute of Physics, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - R Henneck
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - V Hélaine
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - N Hild
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - Z Hodge
- Laboratory for High Energy Physics and Albert Einstein Center for Fundamental Physics, University of Bern, CH-3012 Bern, Switzerland
| | - M Horras
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - P Iaydjiev
- STFC Rutherford Appleton Laboratory, Harwell, Didcot, Oxon OX11 0QX, United Kingdom
| | - S N Ivanov
- STFC Rutherford Appleton Laboratory, Harwell, Didcot, Oxon OX11 0QX, United Kingdom
| | - M Kasprzak
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
- Physics Department, University of Fribourg, CH-1700 Fribourg, Switzerland
| | - Y Kermaidic
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - K Kirch
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - A Knecht
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - P Knowles
- Physics Department, University of Fribourg, CH-1700 Fribourg, Switzerland
| | - H-C Koch
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- Institute of Physics, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
- Physics Department, University of Fribourg, CH-1700 Fribourg, Switzerland
| | - P A Koss
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - S Komposch
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - A Kozela
- Henryk Niedwodniczanski Institute for Nuclear Physics, 31-342 Cracow, Poland
| | - A Kraft
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- Institute of Physics, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - J Krempel
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - M Kuźniak
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- Marian Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Cracow, Poland
| | - B Lauss
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - T Lefort
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - Y Lemière
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - A Leredde
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - P Mohanmurthy
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | | | - M Musgrave
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - O Naviliat-Cuncic
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - D Pais
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - F M Piegsa
- Laboratory for High Energy Physics and Albert Einstein Center for Fundamental Physics, University of Bern, CH-3012 Bern, Switzerland
| | - E Pierre
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - G Pignol
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - C Plonka-Spehr
- Department of Chemistry - TRIGA site, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - P N Prashanth
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - G Quéméner
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - M Rawlik
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - D Rebreyend
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - I Rienäcker
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
| | - D Ries
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
- Department of Chemistry - TRIGA site, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - S Roccia
- Institut Laue-Langevin, CS 20156 F-38042 Grenoble Cedex 9, France
- CSNSM, Université Paris Sud, CNRS/IN2P3, F-91405 Orsay Campus, France
| | - G Rogel
- LPC Caen, ENSICAEN, Université de Caen, CNRS/IN2P3, 14000 Caen, France
| | - D Rozpedzik
- Marian Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Cracow, Poland
| | - A Schnabel
- Physikalisch Technische Bundesanstalt, D-10587 Berlin, Germany
| | | | - N Severijns
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - D Shiers
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - R Tavakoli Dinani
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - J A Thorne
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
- Laboratory for High Energy Physics and Albert Einstein Center for Fundamental Physics, University of Bern, CH-3012 Bern, Switzerland
| | - R Virot
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38026 Grenoble, France
| | - J Voigt
- Physikalisch Technische Bundesanstalt, D-10587 Berlin, Germany
| | - A Weis
- Physics Department, University of Fribourg, CH-1700 Fribourg, Switzerland
| | - E Wursten
- Instituut voor Kern- en Stralingsfysica, University of Leuven, B-3001 Leuven, Belgium
| | - G Wyszynski
- ETH Zürich, Institute for Particle Physics and Astrophysics, CH-8093 Zürich, Switzerland
- Marian Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Cracow, Poland
| | - J Zejma
- Marian Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Cracow, Poland
| | - J Zenner
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
- Department of Chemistry - TRIGA site, Johannes Gutenberg University Mainz, 55128 Mainz, Germany
| | - G Zsigmond
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| |
Collapse
|
15
|
LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil S. Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults. J Med Microbiol 2020; 69:256-264. [PMID: 31264957 PMCID: PMC7431100 DOI: 10.1099/jmm.0.001032] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Accepted: 06/16/2019] [Indexed: 01/04/2023] Open
Abstract
Background. The Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN SOS) has been performing active influenza surveillance since 2009 (ClinicalTrials.gov identifier: NCT01517191). Influenza A and B viruses are identified and characterized using real-time reverse-transcriptase polymerase chain reaction (RT-PCR), and multiplex testing has been performed on a subset of patients to identify other respiratory virus aetiologies. Since both methods can identify influenza A and B, a direct comparison was performed.Methods. Validated real-time RT-PCRs from the World Health Organization (WHO) to identify influenza A and B viruses, characterize influenza A viruses into the H1N1 or H3N2 subtypes and describe influenza B viruses belonging to the Yamagata or Victoria lineages. In a subset of patients, the Seeplex RV15 One-Step ACE Detection assay (RV15) kit was also used for the detection of other respiratory viruses.Results. In total, 1111 nasopharyngeal swabs were tested by RV15 and real-time RT-PCRs for influenza A and B identification and characterization. For influenza A, RV15 showed 98.0 % sensitivity, 100 % specificity and 99.7 % accuracy. The performance characteristics of RV15 were similar for influenza A subtypes H1N1 and H3N2. For influenza B, RV15 had 99.2 % sensitivity, 100 % specificity and 99.8 % accuracy, with similar assay performance being shown for both the Yamagata and Victoria lineages.Conclusions. Overall, the detection of circulating subtypes of influenza A and lineages of influenza B by RV15 was similar to detection by real-time RT-PCR. Multiplex testing with RV15 allows for a more comprehensive respiratory virus surveillance in hospitalized adults, without significantly compromising the reliability of influenza A or B virus detection.
Collapse
Affiliation(s)
- J. J. LeBlanc
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - M. ElSherif
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - S. Mulpuru
- Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
| | - M. Warhuus
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - A. Ambrose
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - M. Andrew
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - G. Boivin
- Centre Hospitalier Universitaire de Québec, QC, Canada
| | - W. Bowie
- University of British Columbia, Vancouver, BC, Canada
| | - A. Chit
- Sanofi Pasteur, Swiftwater, PA, USA
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
| | - G. Dos Santos
- Business & Decision Life Sciences (on behalf of GSK), Bruxelles, Belgium
- Present address: GSK, Wavre, Belgium
| | - K. Green
- Mount Sinai Hospital, Toronto, ON, Canada
| | - S. A. Halperin
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - T. F. Hatchette
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - B. Ibarguchi
- GSK, Mississauga, ON, Canada
- Present address: Bayer, Inc., Mississauga, Ontario, Canada
| | - J. Johnstone
- Public Health Ontario and University of Toronto, Toronto, ON, Canada
| | - K. Katz
- North York General Hospital, Toronto, ON, Canada
| | - J. M. Langley
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | | | - M. Loeb
- Public Health Ontario and University of Toronto, Toronto, ON, Canada
| | - A. Lund
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - D. MacKinnon-Cameron
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - A. McCarthy
- Ottawa Hospital General, Ottawa, Ontario, Canada
| | - J. E. McElhaney
- Health Sciences North Research Institute, Sudbury, ON, Canada
| | - A. McGeer
- Mount Sinai Hospital, Toronto, ON, Canada
| | - A. Poirier
- Centre Intégré Universitaire de Santé et Services Sociaux, Quebec, QC, Canada
| | - J. Powis
- Toronto East General Hospital, Toronto, ON, Canada
| | | | - M. Semret
- McGill University, Montreal, QC, Canada
| | - V. Shinde
- GSK, King of Prussia, PA, USA
- Present address: Novavax Vaccines, Washington, DC, USA
| | - D. Smyth
- The Moncton Hospital, Moncton, NB, Canada
| | - S. Trottier
- Centre Hospitalier Universitaire de Québec, QC, Canada
| | | | | | - L. Ye
- Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, NS, Canada
| | - S. A. McNeil
- Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
| |
Collapse
|
16
|
Duric D, Anwar A, Green K, Edwards C, Singh I. 47BURDEN OF OSTEOPOROSIS IN ACUTE OLDER PATIENTS IN THE HOSPITAL: IMPACT OF QUALITY INITIATIVES. Age Ageing 2019. [DOI: 10.1093/ageing/afz076.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- D Duric
- Department of Geriatric Medicine, Ysbyty Ystrad Fawr, Aneurin Bevan University Health Board, Wales
| | - A Anwar
- Department of Geriatric Medicine, Ysbyty Ystrad Fawr, Aneurin Bevan University Health Board, Wales
| | - K Green
- Department of Geriatric Medicine, Ysbyty Ystrad Fawr, Aneurin Bevan University Health Board, Wales
| | - C Edwards
- Department of Geriatric Medicine, Ysbyty Ystrad Fawr, Aneurin Bevan University Health Board, Wales
| | - I Singh
- Department of Geriatric Medicine, Ysbyty Ystrad Fawr, Aneurin Bevan University Health Board, Wales
| |
Collapse
|
17
|
Voldby C, Green K, Kongstad T, Ring A, Sandvik R, Skov M, Buchvald F, Pressler T, Nielsen K. P186 Impact of bronchoalveolar lavage and related treatment on clinical outcomes in children with cystic fibrosis based on increases in the Lung Clearance Index. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30480-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
18
|
Roth-Carter Q, Arnette C, Koetsier J, Broussard J, Burks H, Gerami P, Johnson J, Green K. 825 Keratinocyte desmoglein 1 controls keratinocyte/melanocyte paracrine signaling to regulate the tanning response. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Hegazy M, Nekrasova O, Koetsier J, Broussard J, Godsel L, Green K. 436 The role of the endosomal trafficking complex, the retromer, in regulating desmoglein-1 localization. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Cohen Barak E, Godsel L, Koetsier J, Kushnir D, Hammad H, Farran N, Sarig O, Johnson J, Ziv M, Shalev S, Sprecher E, Green K. 381 Desmoglein 1 role in gap junction turnover revealed through the study of SAM syndrome. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.457] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Bui T, Tran B, Green K, Wadhwani C, McGuire H. PO551 Attacking Hypertension From All Sides: Improving Hypertension Prevention and Control In Vietnam Through a Holistic Multi-Stakeholder Approach. Glob Heart 2018. [DOI: 10.1016/j.gheart.2018.09.422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
22
|
Green K, Hoang Bich Tran K, Viet Nguyen D, Bui T, Wadhwani C. PO236 From Traditional to Disruptive: Utilizing New Partners to Promote Early Detection of Hypertension In Vietnam. Glob Heart 2018. [DOI: 10.1016/j.gheart.2018.09.199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
23
|
Mai S, Bui T, Tran H, Dao S, Vu C, Green K, McGuire H, Wadhwani C, Cotrel-Gibbons L. PO041 Making Digital Technology and Data Work For Better Hypertension Management In Vietnam. Glob Heart 2018. [DOI: 10.1016/j.gheart.2018.09.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
24
|
Traviss-Turner GD, Philpot U, Wilton J, Green K, Heywood-Everett S, Hill AJ. Guided self-help to manage binge eating in a dietetic-led community weight management service. Clin Obes 2018; 8:250-257. [PMID: 29900680 DOI: 10.1111/cob.12259] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/21/2018] [Revised: 04/06/2018] [Accepted: 05/04/2018] [Indexed: 01/06/2023]
Abstract
An estimated 30% of patients accessing community weight management services experience symptoms of binge eating disorder (BED). Guided self-help (GSH) is the recommended first line of treatment for BED. This study is a preliminary investigation into the effectiveness of GSH delivered by dietitians for patients with binge eating within a weight management service and a consideration of the association between wellbeing, therapeutic relationship and outcomes. The study was conducted as a single group, pre- and post-intervention study with 24 patients reporting symptoms of binge eating who completed the self-help manual with guidance from a trained community dietitian. Primary outcomes were eating disorder psychopathology and behaviours (Eating Disorder Evaluation Questionnaire), depression and anxiety. Principle results showed a significant reduction on all subscales of eating disorder psychopathology, anxiety and depression. There was a reduction in loss of control over eating but the 40% reduction in binge episodes was not statistically significant. Mid-treatment sessional ratings were positively associated with outcome. In conclusion, the GSH intervention was appropriate for dietitian delivery to patients with obesity and binge eating behaviour. This research indicates potential for other dietetic-led weight management services to deliver such interventions and support patients with binge eating accessing their service.
Collapse
Affiliation(s)
- G D Traviss-Turner
- Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK
| | - U Philpot
- School of Clinical & Applied Sciences, Leeds Beckett University, Leeds, UK
| | - J Wilton
- Dietetic Department, Leeds General Infirmary, Leeds, UK
| | - K Green
- School of Clinical & Applied Sciences, Leeds Beckett University, Leeds, UK
| | - S Heywood-Everett
- Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK
| | - A J Hill
- Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK
| |
Collapse
|
25
|
Vodo D, O'Toole E, Malchin N, Lahav A, Adir N, Sarig O, Green K, Sprecher E. 773 Striate palmoplantar keratoderma resulting from a missense mutation in DSG1. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Gutowski E, Silvester J, Rigaux L, Green K, Weiten D, Bernstein CN, Walker JR, Graff LA, Duerksen D. A170 CANADIANS WITH CELIAC DISEASE MISINTERPRET PRODUCT LABEL INFORMATION WHICH MAY LEAD TO UNSAFE FOOD CHOICES DESPITE ALLERGEN LABELLING LAWS. J Can Assoc Gastroenterol 2018. [DOI: 10.1093/jcag/gwy009.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- E Gutowski
- Harvard Celiac Disease Program, Boston, MA
| | | | - L Rigaux
- St Boniface Hospital, Winnipeg, MB, Canada
| | - K Green
- St Boniface Hospital, Winnipeg, MB, Canada
| | - D Weiten
- Grace General Hospital, Winnipeg, MB, Canada
| | | | | | - L A Graff
- Clinical Health Psychology, University of Manitoba, Winnipeg, MB, Canada
| | | |
Collapse
|
27
|
Atsawarungruangkit A, Silvester J, Weiten D, Green K, Wilkey K, Rigaux L, Bernstein CN, Graff LA, Walker JR, Duerksen D. A171 DEVELOPMENT AND VALIDATION OF THE DIETITIAN INTEGRATED EVALUATION TOOL FOR GLUTEN-FREE DIETS (DIET-GFD). J Can Assoc Gastroenterol 2018. [DOI: 10.1093/jcag/gwy009.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - J Silvester
- Harvard Center for Celiac Disease Research, Boston, MA, Boston, MA
| | - D Weiten
- Grace General Hospital, Winnipeg, MB, Canada
| | - K Green
- St. Boniface Hospital, Winnipeg, MB, Canada
| | - K Wilkey
- Harvard Center for Celiac Disease Research, Boston, MA, Boston, MA
| | - L Rigaux
- St. Boniface Hospital, Winnipeg, MB, Canada
| | - C N Bernstein
- Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - L A Graff
- Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - J R Walker
- Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - D Duerksen
- Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
28
|
Eli S, Abam DS, B Kalio DG, Oriji V, Allagua DO, Green K, Ikimalo J. Ruptured uterus: Fetomaternal outcome among unbooked mothers and antenatal care defaulters at the university of portharcourt teaching hospital. Niger J Med 2018. [DOI: 10.4103/1115-2613.278229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
29
|
Wang H, Green K, Pressler T, Katzenstein T, Wu X, Høiby N. 181 Optimization of high dosing regimens of colistin in cystic fibrosis patients with Pseudomonas aeruginosa. J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30545-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
30
|
Hjermind S, Green K, Ring A, Kongstad T, Buchvald F, Skov M, Moser C, Pressler T, Nielsen K. WS19.3 Does lung clearance index (LCI) reflect levels of IL-8 and IL-1β in BAL fluids from children with stable CF pulmonary disease? J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30264-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
31
|
Abstract
To understand the recent elevational range expansion of European rabbits (Oryctolagus cuniculus) with declining snow cover and earlier snow thaw we examined their diet in relation to that of long-term residents, common wombats (Vombatus ursinus). The colonisation of eastern Australia by rabbits was effectively completed by 1910 when they reached an elevation of 1500 m (the winter snowline). Rabbits began to penetrate higher elevations only from the 1970s in association with anthropogenic habitat modification. Since 2011, rabbits have occupied elevations to the alpine treeline (~1850 m) throughout the year without the ameliorating presence of infrastructure or anthropogenically modified vegetation. Rabbits and wombats are both grazers preferring grasses (largely inaccessible beneath winter snow) and are spatially restricted in their foraging by their need to return to their burrows. Wombats used a much wider foraging range, enabling them to select preferred food. Rabbits, with a much smaller range, were constrained in their choice of forage mainly to plants that projected above the snow. Unexpectedly, rabbits fed intensively on leaves of eucalypts, food not typically consumed in substantial quantities by this species. These leaves, on stems regenerating after fire, will diminish in availability as stems mature, possibly halting the range expansion of rabbits.
Collapse
|
32
|
Abstract
The small extent of seasonally snow-covered Australian mountains means that there has not been a great selective pressure on the mammalian fauna for adaptations to this environment. Only one large marsupial, the common wombat (Vombatus ursinus (Shaw, 1800)), is widespread above the winter snowline. In the past 20 years, with snow depth and duration declining, the swamp wallaby (Wallabia bicolor (Desmarest, 1804)) has become more common above the winter snowline. The red-necked wallaby (Macropus rufogriseus (Desmarest, 1817)) is common in alpine Tasmania where seasonal snow cover is neither as deep nor as long-lasting as on the mainland, but has only been recorded regularly above the winter snowline in the mainland Snowy Mountains since 2011. This study examines morphological aspects of locomotion of these three herbivorous marsupials in snow. The wombat is the best adapted to snow, with quadrupedal gait and an expanded home range allowing it to locate and feed on the same plant groups as it does at lower elevation. Wallabies are poorly adapted to locomotion in snow, but the browsing swamp wallaby is able to maintain its dietary habit by feeding on exposed shrubs in deep snow, whereas the red-necked wallaby, which depends more on grazing, appears constrained to areas where snow is shallow.
Collapse
Affiliation(s)
- K. Green
- National Parks and Wildlife Service, Snowy Mountains Region, P.O. Box 2228, Jindabyne, NSW 2627, Australia
- National Parks and Wildlife Service, Snowy Mountains Region, P.O. Box 2228, Jindabyne, NSW 2627, Australia
| |
Collapse
|
33
|
Kourosh A, Hasan S, Parsi S, Green K, Minard C, Noroski L. P013 Anaphylaxis recognition and action: needs assessment-quality improvement empowers tertiary care allergy clinic team. Ann Allergy Asthma Immunol 2016. [DOI: 10.1016/j.anai.2016.09.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Egner W, Sargur R, Shrimpton A, York M, Green K. A 17-year experience in perioperative anaphylaxis 1998-2015: harmonizing optimal detection of mast cell mediator release. Clin Exp Allergy 2016; 46:1465-1473. [DOI: 10.1111/cea.12785] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2015] [Revised: 05/24/2016] [Accepted: 07/20/2016] [Indexed: 12/20/2022]
Affiliation(s)
- W. Egner
- Clinical Immunology and Allergy Unit and Department of Immunology and Protein Reference Unit; Sheffield Teaching Hospitals NHS Trust; Sheffield UK
| | - R. Sargur
- Clinical Immunology and Allergy Unit and Department of Immunology and Protein Reference Unit; Sheffield Teaching Hospitals NHS Trust; Sheffield UK
| | - A. Shrimpton
- Clinical Immunology and Allergy Unit and Department of Immunology and Protein Reference Unit; Sheffield Teaching Hospitals NHS Trust; Sheffield UK
| | - M. York
- Clinical Immunology and Allergy Unit and Department of Immunology and Protein Reference Unit; Sheffield Teaching Hospitals NHS Trust; Sheffield UK
| | - K. Green
- Clinical Immunology and Allergy Unit and Department of Immunology and Protein Reference Unit; Sheffield Teaching Hospitals NHS Trust; Sheffield UK
| |
Collapse
|
35
|
Franasiak JM, Wang X, Molinaro TA, Green K, Sun W, Werner MD, Juneau CR, Scott RT. Free vitamin D does not vary through the follicular phase of the menstrual cycle. Endocrine 2016; 53:322-6. [PMID: 27052515 DOI: 10.1007/s12020-016-0946-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Accepted: 03/28/2016] [Indexed: 12/11/2022]
Abstract
The importance of vitamin D (25OHD) in general health and reproductive success has been a focus in the setting of the 25OHD deficiency epidemic. However, there are challenges to understanding 25OHD's effects. The free and bioavailable levels are affected by 25OHD binding protein (DBP) and it is not known how estradiol fluctuations during the menstrual cycle affect these binding parameters. This may impact the most appropriate time to measure 25OHD when determining deficiency. This study characterizes 25OHD throughout the follicular phase of the menstrual cycle. Patients undergoing natural cycle IVF were included. Serum was drawn throughout the follicular phase of the menstrual cycle; 25OHD, DBP, albumin, and estrogen levels were determined for each time point allowing for mathematical calculation of free and bioavailable 25OHD. Early, mid, and late follicular phases were designated by estrogen tertiles among patients. Mean Levels of 25OHD (total, free, bioavailable) and DBP for each tertile were compared with Kruskil-Wallis test for non-parametric groups. Linear regression with GEE was employed due to repeated measures within participants. A total of 33 patients were included with 202 total serum measurements. There was no difference in mean levels of 25OHD (p = 0.77), free 25OHD (p = 0.91), and bioavailable 25OHD (p = 0.76) when measured throughout the follicular phase of the menstrual cycle. Vitamin D metabolism does not fluctuate as estradiol changes in the follicular phase of the menstrual cycle. This data indicates that assessment of 25OHD, in particular when assessed for associations with reproductive outcomes, can be measured reliably at any point during the follicular phase of the menstrual cycle.
Collapse
Affiliation(s)
- J M Franasiak
- Division of Reproductive Endocrinology, Department of Obstetrics Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
- Reproductive Medicine Associates of New Jersey, 140 Allen Road, Basking Ridge, NJ, 07920, USA.
| | - X Wang
- Division of Endocrinology, Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
| | - T A Molinaro
- Division of Reproductive Endocrinology, Department of Obstetrics Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- Reproductive Medicine Associates of New Jersey, 140 Allen Road, Basking Ridge, NJ, 07920, USA
| | - K Green
- Division of Reproductive Endocrinology, National Institute of Health and Human Services, Bethesda, MD, USA
| | - W Sun
- Division of Endocrinology, Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
| | - M D Werner
- Division of Reproductive Endocrinology, Department of Obstetrics Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- Reproductive Medicine Associates of New Jersey, 140 Allen Road, Basking Ridge, NJ, 07920, USA
| | - C R Juneau
- Division of Reproductive Endocrinology, Department of Obstetrics Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- Reproductive Medicine Associates of New Jersey, 140 Allen Road, Basking Ridge, NJ, 07920, USA
| | - R T Scott
- Division of Reproductive Endocrinology, Department of Obstetrics Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- Reproductive Medicine Associates of New Jersey, 140 Allen Road, Basking Ridge, NJ, 07920, USA
| |
Collapse
|
36
|
Johnson J, Koetsier J, Godsel L, Todorovic V, Green K. 099 Novel roles for plakophilin 3 in cell cycle regulation in head and neck squamous cell carcinoma cells. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
37
|
Bochner R, Samuelov L, Sarig O, Li Q, Koetsier J, Adase C, Isakov O, Malchin N, Vodo D, Shayevitch R, Yu B, Fainberg G, Harmon R, Najor N, Godsel L, Warshauer E, Gat A, Goldberg I, Shomron N, Ast G, McLean W, Gallo R, Uitto J, Green K, Sprecher E. 372 CAPN12 function revealed through the study of an atypical case of autosomal recessive congenital ichthyosis. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Albrecht L, Green K. 420 AMPK activation promotes desmosome recovery in Darier’s disease cells by restoring desmoplakin-intermediate filament dynamics. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Najor N, Koetsier J, Fitz G, Albrecht L, Green K. 340 A novel desmosome-cop9 signalosome interaction: a role in epidermal differentiation and egfr neddylation. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
Eskin-Schwartz M, Drozhdina M, Sarig O, Jackman T, Isakov O, Samuelov L, Malchin N, Peled A, Vodo D, Shomron N, Ruzicka T, Koshkin S, Green K, Paller A, Sprecher E. 381 Epidermolytic ichthyosis sine epidermolysis. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.414] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
41
|
Lee S, Harmon R, Nekrasova O, Johnson J, Green K. 336 The antioxidant enzyme peroxiredoxin 1 stabilizes desmoglein 1 at the plasma membrane to promote epidermal differentiation. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
42
|
Komarov AP, Komarova EA, Green K, Novototskaya LR, Baker PS, Eroshkin A, Osterman AL, Chenchick AA, Frangou C, Gudkov AV. Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure. Cell Death Dis 2016; 7:e2145. [PMID: 26986512 PMCID: PMC4823946 DOI: 10.1038/cddis.2016.45] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2016] [Revised: 01/25/2016] [Accepted: 02/04/2016] [Indexed: 12/12/2022]
Abstract
shRNA-mediated gene-silencing technology paired with cell-based functional readouts reveals potential targets directly, providing an opportunity to identify drugs against the target without knowing the precise role of the target in the pathophysiological processes of interest. By screening a lentiviral shRNA library targeting for major components of human signaling pathways and known drug targets, we identified and validated both canonical as well as 52 novel mediators of FAS and TNF ligand-induced apoptosis. Presence of potential therapeutic targets among these mediators was confirmed by demonstration of in vivo activity of siRNAs against four identified target candidates that protected mice from acute liver failure (ALF), a life-threatening disease with known involvement of death receptor (DR)-mediated apoptosis. Network-based modeling was used to predict small-molecule inhibitors for several candidate apoptosis mediators, including somatostatin receptor 5 (SSTR5) and a regulatory subunit of PP2A phosphatase, PPP2R5A. Remarkably, pharmacological inhibition of either SSTR5 or PPP2R5A reduced apoptosis induced by either FASL or TNF in cultured cells and dramatically improved survival in several mouse models of ALF. These results demonstrate the utility of loss-of-function genetic screens and network-based drug-repositioning methods for expedited identification of targeted drug candidates and revealed pharmacological agents potentially suitable for treatment of DR-mediated pathologies.
Collapse
Affiliation(s)
| | - E A Komarova
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - K Green
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - L R Novototskaya
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - P S Baker
- Buffalo BioLabs, LLC, Buffalo, NY, USA
| | - A Eroshkin
- Infectious and Inflammatory Disease Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, USA
| | - A L Osterman
- Buffalo BioLabs, LLC, Buffalo, NY, USA.,Infectious and Inflammatory Disease Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, USA
| | | | - C Frangou
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - A V Gudkov
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| |
Collapse
|
43
|
Shek KL, Green K, Hall J, Guzman-Rojas R, Dietz HP. Perineal and vaginal tears are clinical markers for occult levator ani trauma: a retrospective observational study. Ultrasound Obstet Gynecol 2016; 47:224-227. [PMID: 25807920 DOI: 10.1002/uog.14856] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 02/25/2015] [Accepted: 03/20/2015] [Indexed: 06/04/2023]
Abstract
OBJECTIVES Levator avulsion has been shown to be associated with anterior and central compartment prolapse and is a risk factor for prolapse recurrence. Diagnosis in the delivery room is usually impossible, as levator avulsion is commonly occult. The objective of this study was to determine if vaginal and major perineal tears are clinical markers of levator trauma as diagnosed by four-dimensional (4D) translabial ultrasound 3-6 months postpartum. METHODS This was a retrospective observational study using data obtained in two perinatal trials. A total of 774 women seen, on average, 5 (range, 2.3-22.4) months after their first delivery of a term singleton cephalic baby underwent a standardized interview, clinical assessment and 4D translabial ultrasound examination. Clinical data were obtained from the institutional obstetric database, including information on vaginal and perineal tears. Levator avulsion was diagnosed using tomographic ultrasound, with operators blinded to the clinical data. RESULTS Both third- and fourth-degree perineal tears and vaginal sidewall tears were independently associated with levator avulsion (P = 0.004 and P = 0.012, respectively). The odds ratio for avulsion in women suffering from such overt trauma was 3.44 (95% CI, 1.47-8.03) for third-/fourth-degree perineal tears and 3.35 (95% CI, 1.30-8.61) for vaginal sidewall tears. CONCLUSIONS Vaginal sidewall and third-/fourth-degree perineal tears were found to be independent clinical indicators of an increased risk of levator trauma, as diagnosed by 4D translabial ultrasound 3-6 months postpartum. Such clinical markers may become useful in the identification of women at high risk of levator trauma and future pelvic floor disorders.
Collapse
Affiliation(s)
- K L Shek
- Department of Obstetrics and Gynaecology, Liverpool Clinical School, Western Sydney University, Sydney, Australia
- Department of Obstetrics and Gynaecology, Nepean Clinical School, University of Sydney, Sydney, Australia
| | - K Green
- Department of Obstetrics and Gynaecology, Nepean Clinical School, University of Sydney, Sydney, Australia
| | - J Hall
- Department of Obstetrics and Gynaecology, Nepean Clinical School, University of Sydney, Sydney, Australia
| | - R Guzman-Rojas
- Departamento de Ginecología y Obstetricia, Clínica Alemana de Santiago, Santiago, Chile
| | - H P Dietz
- Department of Obstetrics and Gynaecology, Nepean Clinical School, University of Sydney, Sydney, Australia
| |
Collapse
|
44
|
Fernández YB, Green K, Schuler K, Soares A, Vale P, Alibardi L, Cartmell E. Biological carbon dioxide utilisation in food waste anaerobic digesters. Water Res 2015; 87:467-75. [PMID: 26143589 DOI: 10.1016/j.watres.2015.06.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 05/26/2015] [Accepted: 06/05/2015] [Indexed: 05/24/2023]
Abstract
Carbon dioxide (CO2) enrichment of anaerobic digesters (AD) was previously identified as a potential on-site carbon revalorisation strategy. This study addresses the lack of studies investigating this concept in up-scaled units and the need to understand the mechanisms of exogenous CO2 utilisation. Two pilot-scale ADs treating food waste were monitored for 225 days, with the test unit being periodically injected with CO2 using a bubble column. The test AD maintained a CH4 production rate of 0.56 ± 0.13 m(3) CH4·(kg VS(fed) d)(-1) and a CH4 concentration in biogas of 68% even when dissolved CO2 levels were increased by a 3 fold over the control unit. An additional uptake of 0.55 kg of exogenous CO2 was achieved in the test AD during the trial period. A 2.5 fold increase in hydrogen (H2) concentration was observed and attributed to CO2 dissolution and to an alteration of the acidogenesis and acetogenesis pathways. A hypothesis for conversion of exogenous CO2 has been proposed, which requires validation by microbial community analysis.
Collapse
Affiliation(s)
| | - K Green
- Cranfield University, Cranfield, Bedfordshire, MK43 0AL, UK
| | - K Schuler
- Ecole Nationale Supérieure de Chimie de Rennes, 11 Allée de Beaulieu, 35708 Rennes Cedex 7, France
| | - A Soares
- Cranfield University, Cranfield, Bedfordshire, MK43 0AL, UK
| | - P Vale
- Severn Trent Water, 2 St John's Street, Coventry, CV1 2LZ, UK
| | - L Alibardi
- Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, Italy
| | - E Cartmell
- Cranfield University, Cranfield, Bedfordshire, MK43 0AL, UK.
| |
Collapse
|
45
|
Onyango MA, Adu-Sarkodie Y, Adjei R, Poku TA, Green K, Wambugu S, Falconer A, Kopelman CH, Beard J. O12.2 Understanding the relationship dynamics between female sex workers and their intimate partners in kumasi, ghana. Br J Vener Dis 2015. [DOI: 10.1136/sextrans-2015-052270.143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
46
|
Green K, Boston SE. Bilateral removal of the mandibular and medial retropharyngeal lymph nodes through a single ventral midline incision for staging of head and neck cancers in dogs: a description of surgical technique. Vet Comp Oncol 2015; 15:208-214. [DOI: 10.1111/vco.12154] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2014] [Revised: 04/13/2015] [Accepted: 04/14/2015] [Indexed: 11/29/2022]
Affiliation(s)
- K. Green
- Department of Small Animal Clinical Sciences; College of Veterinary Medicine, University of Florida; Gainesville FL USA
| | - S. E. Boston
- Department of Small Animal Clinical Sciences; College of Veterinary Medicine, University of Florida; Gainesville FL USA
| |
Collapse
|
47
|
Dandona P, Ghanim H, Sia CL, Green K, Abuaysheh S, Dhindsa S, Chaudhuri A, Makdissi A. A mixed anti-inflammatory and pro-inflammatory response associated with a high dose of corticosteroids. Curr Mol Med 2015; 14:793-801. [PMID: 25056537 DOI: 10.2174/1566524014666140724105557] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Revised: 06/10/2014] [Accepted: 06/11/2014] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Hydrocortisone, at a low dose (100 mg), induces an anti-inflammatory response including inducing IkBα and suppressing intranuclear NFκB and AP-1 binding and the expression of pro-inflammatory mediators like MMPs. We have now investigated the effect of a high dose of hydrocortisone (300mg=60 mg prednisolone) on NFκB binding and the expression of TLRs, the mediators of TLR signal transduction, MyD88 and TRIF and HMG-B1. DESIGN AND SUBJECTS A 300mg of hydrocortisone or saline was injected intravenously in ten normal subjects during 2 separate visits, in a randomized crossover study. Blood samples were obtained at 0, 1, 4, 6 and 24h after the injection and mononuclear cells (MNC) were prepared. RESULTS There was a significant increase in glucose (from 92±4 to 116±6 mg/dl), insulin (from 4.5±0.7 to 5.3±0.8 mU/ml) and FFA concentrations (from 0.38±0.1 to 0.80±0.15mM) following the administration of hydrocortisone compared to placebo treatment. While NFκB binding and the mRNA expression of MyD88, TRIF, chemokines and chemokine receptors were suppressed significantly in MNC, there was a paradoxical increase in the mRNA expression of TLR 2, 5 and 9 and HMG-B1 was increased by 103±24%, 107±19%, 56±13% and 58±12% above the baseline, respectively in the MNC. Plasma concentrations of HMG-B1 and MMP-9 increased by 37±12% and 125±22%, respectively, while TNF-α concentrations fell by 27±9%. CONCLUSION While this high dose of hydrocortisone exerts a powerful anti-inflammatory effect, it also exerts certain proinflammatory effects mainly on TLRs expression. The known pro-inflammatory effects of glucose and FFAs may have contributed to these effects. These paradoxical pro-inflammatory effects may account for the inability of these drugs to show benefit in clinical trials of septicemia and other severe pro-inflammatory states and might contribute to some of the side effects of corticosteroids use.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - A Makdissi
- Division of Endocrinology, State University of New York at Buffalo, 115 Flint Rd, Williamsville, NY 14221, USA.
| |
Collapse
|
48
|
Pinder N, Amelung S, Horscht J, Lukasova M, Paasch S, Green K, Hoppe-Tichy T. CP-012 Medicines reconciliation ñ implementation by clinical pharmacists in the otorhinolaryngology clinic. Eur J Hosp Pharm 2015. [DOI: 10.1136/ejhpharm-2015-000639.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
49
|
Langebrake C, Hug MJ, Först G, Green K, Tanja M, Sommer C, Seidling HM. PS-120 Challenges in evaluation of electronic switch modules for home medication. Eur J Hosp Pharm 2015. [DOI: 10.1136/ejhpharm-2015-000639.441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
50
|
Barrow P, Green K, Clancy T, Lalloo F, Hill J, Evans D. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey. Clin Genet 2015; 87:517-24. [DOI: 10.1111/cge.12559] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2014] [Revised: 01/07/2015] [Accepted: 01/08/2015] [Indexed: 12/20/2022]
Affiliation(s)
- P. Barrow
- Department of Colorectal Surgery, Manchester Royal Infirmary; Manchester UK
| | - K. Green
- Manchester Centre for Genomic Medicine; Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC); Manchester UK
| | - T. Clancy
- Manchester Centre for Genomic Medicine; Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC); Manchester UK
- Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences; University of Manchester, MAHSC; Manchester UK
| | - F. Lalloo
- Manchester Centre for Genomic Medicine; Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC); Manchester UK
- Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences; University of Manchester, MAHSC; Manchester UK
| | - J. Hill
- Department of Colorectal Surgery, Manchester Royal Infirmary; Manchester UK
| | - D.G. Evans
- Manchester Centre for Genomic Medicine; Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC); Manchester UK
- Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences; University of Manchester, MAHSC; Manchester UK
| |
Collapse
|